Covered recipient · General Payments record
JADE LEE WILKIE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,164.65
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $772.61 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $311.78 | 24 |
| Regeneron Healthcare Solutions, Inc. | $114.56 | 1 |
| Dermavant Sciences, Inc. | $105.76 | 1 |
| GENZYME CORPORATION | $52.75 | 2 |
| REVANCE THERAPEUTICS, INC. | $49.95 | 1 |
| Janssen Biotech, Inc. | $36.18 | 2 |
| BioWound Solutions, Inc. | $35.74 | 1 |
| Galderma Laboratories, L.P. | $31.61 | 1 |
| ORGANOGENESIS INC. | $23.74 | 1 |
| Biofrontera Inc. | $10.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.52 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411971 | CMS |
| ABBVIE INC. | $11.77 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411973 | CMS |
| ABBVIE INC. | $7.86 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411975 | CMS |
| ABBVIE INC. | $11.14 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411977 | CMS |
| ABBVIE INC. | $11.14 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411979 | CMS |
| ABBVIE INC. | $5.31 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411981 | CMS |
| ABBVIE INC. | $10.66 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411983 | CMS |
| ABBVIE INC. | $10.66 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411985 | CMS |
| ABBVIE INC. | $18.17 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411987 | CMS |
| ABBVIE INC. | $17.84 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411989 | CMS |
| ABBVIE INC. | $18.50 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411991 | CMS |
| ABBVIE INC. | $14.79 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411993 | CMS |
| ABBVIE INC. | $20.39 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411995 | CMS |
| ABBVIE INC. | $1.05 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411997 | CMS |
| ABBVIE INC. | $11.24 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108411999 | CMS |
| ABBVIE INC. | $17.60 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412001 | CMS |
| ABBVIE INC. | $11.57 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412003 | CMS |
| ABBVIE INC. | $11.56 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412005 | CMS |
| ABBVIE INC. | $27.58 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412007 | CMS |
| ABBVIE INC. | $9.34 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412009 | CMS |
| ABBVIE INC. | $20.21 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412011 | CMS |
| ABBVIE INC. | $20.28 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412013 | CMS |
| ABBVIE INC. | $3.38 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412015 | CMS |
| ABBVIE INC. | $1.22 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108412017 | CMS |
| Biofrontera Inc. | $10.54 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095484926 | CMS |
| BioWound Solutions, Inc. | $35.74 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118399544 | CMS |
| Dermavant Sciences, Inc. | $105.76 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128024540 | CMS |
| Galderma Laboratories, L.P. | $31.61 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145400806 | CMS |
| GENZYME CORPORATION | $22.50 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139815349 | CMS |
| GENZYME CORPORATION | $30.25 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139815391 | CMS |
| Janssen Biotech, Inc. | $14.03 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078668941 | CMS |
| Janssen Biotech, Inc. | $22.15 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078666745 | CMS |
| Organogenesis Inc. | $23.74 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145465817 | CMS |
| Regeneron Healthcare Solutions, Inc. | $114.56 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114390765 | CMS |
| REVANCE THERAPEUTICS, INC. | $49.95 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147953828 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.